全文获取类型
收费全文 | 1068124篇 |
免费 | 73088篇 |
国内免费 | 1363篇 |
学科分类
医药卫生 | 1142575篇 |
出版年
2019年 | 7764篇 |
2018年 | 11303篇 |
2017年 | 8913篇 |
2016年 | 10108篇 |
2015年 | 11279篇 |
2014年 | 15282篇 |
2013年 | 22222篇 |
2012年 | 30570篇 |
2011年 | 32315篇 |
2010年 | 18964篇 |
2009年 | 17824篇 |
2008年 | 29974篇 |
2007年 | 32099篇 |
2006年 | 32748篇 |
2005年 | 31093篇 |
2004年 | 29761篇 |
2003年 | 28589篇 |
2002年 | 27542篇 |
2001年 | 59971篇 |
2000年 | 61379篇 |
1999年 | 50722篇 |
1998年 | 11850篇 |
1997年 | 10393篇 |
1996年 | 10338篇 |
1995年 | 10281篇 |
1994年 | 9319篇 |
1993年 | 8819篇 |
1992年 | 37772篇 |
1991年 | 36279篇 |
1990年 | 35734篇 |
1989年 | 34281篇 |
1988年 | 30853篇 |
1987年 | 29979篇 |
1986年 | 28208篇 |
1985年 | 26444篇 |
1984年 | 19176篇 |
1983年 | 16090篇 |
1982年 | 8793篇 |
1979年 | 16995篇 |
1978年 | 11377篇 |
1977年 | 10193篇 |
1976年 | 8822篇 |
1975年 | 10047篇 |
1974年 | 11636篇 |
1973年 | 11259篇 |
1972年 | 10744篇 |
1971年 | 10085篇 |
1970年 | 9243篇 |
1969年 | 8925篇 |
1968年 | 7909篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
Molnár B. Aroca S. Dobos A. Orbán K. Szabó J. Windisch P. Stähli A. Sculean A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with... 相似文献
22.
The advent of precision medicine has changed the landscape of oncologic biomarkers, drug discovery, drug development, and, more importantly, outcomes for patients with cancer. Precision oncology entails the genomic profiling of tumors to detect actionable aberrations. The advances in clinical next-generation sequencing from both tumor tissue and liquid biopsy and availability of targeted therapies has rapidly entered mainstream clinical practice. In this review, recent major developments in precision oncology that have affected outcomes for patients with cancer are discussed. Rapid clinical development was seen of targeted agents across various mutational profiles such as KRASG12C (which was considered “undruggable” for almost 4 decades), Exon 20 insertions, and RET mutations. Approaches to precision chemotherapy delivery by the introduction of antibody drug conjugates in the armamentarium against lung cancer has been appreciated. 相似文献
23.
24.
25.
26.
Jesus K Yamamoto-Furusho Norma N Parra-Holgu n 《World journal of gastroenterology : WJG》2021,27(48):8242-8261
Inflammatory bowel disease (IBD) is a chronic disease that requires chronic treatment throughout the evolution of the disease, with a complex physiopathology that entails great challenges for the development of new and specific treatments for ulcerative colitis and Crohn´s disease. The anti-tumor necrosis factor alpha therapy has impacted the clinical course of IBD in those patients who do not respond to conventional treatment, so there is a need to develop new therapies and markers of treatment response. Various pathways involved in the development of the disease are known and the new therapies have focused on blocking the inflammatory process at the gastrointestinal level by oral, intravenous, subcutaneous, and topical route. All these new therapies can lead to more personalized treatments with higher success rates and fewer relapses. These treatments have not only focused on clinical remission, but also on achieving macroscopic changes at the endoscopic level and microscopic changes by achieving mucosal healing. These treatments are mainly based on modifying signaling pathways, by blocking receptors or ligands, reducing cell migration and maintaining the integrity of the epithelial barrier. Therefore, this review presents the efficacy and safety of the new treatments that are currently under study and the advances that have been made in this area in recent years. 相似文献
27.
28.
European Journal of Epidemiology - Higher parental age at childbearing has generated much attention as a potential risk factor for birth disorders; however, previous research findings are mixed.... 相似文献
29.